Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Transdermal Testosterone for Low Libido in Women
NCT02215434Phase 2Completed
- Sponsor
- Universidade Potiguar
- Start
- Sep 2009
- Primary completion
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial in hypoactive sexual desire disorder (HSDD) comparing Placebo with Testosterone (2 arms). Primary endpoints: Satisfactory Sexual Events at 12 weeks and Sabbatsberg Sexual Self-rating Scale at 12 weeks. Started Sep 2009; status: completed.
02
Drugs
testosterone
03
Conditions
hypoactive sexual desire disorder (HSDD)
Beyond the preview
Go deeper on NCT02215434.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02215434.